Tissue Regenix (UK) Buy Hold or Sell Recommendation
| TRX Stock | 58.50 1.50 2.50% |
Assuming the 90 days trading horizon and your conservative risk appetite, our recommendation regarding Tissue Regenix Group is 'Not Rated'. Macroaxis provides Tissue Regenix buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TRX positions.
Check out Tissue Regenix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Tissue and provide practical buy, sell, or hold advice based on investors' constraints. Tissue Regenix Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Tissue |
Execute Tissue Regenix Buy or Sell Advice
The Tissue recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Tissue Regenix Group. Macroaxis does not own or have any residual interests in Tissue Regenix Group or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Tissue Regenix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Tissue Regenix Trading Alerts and Improvement Suggestions
| The company reported the revenue of 29.49 M. Net Loss for the year was (1.67 M) with profit before overhead, payroll, taxes, and interest of 11.26 M. | |
| About 52.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Tissue Regenix Sees Shift in IP Group Voting Rights - TipRanks |
Tissue Regenix Returns Distribution Density
The distribution of Tissue Regenix's historical returns is an attempt to chart the uncertainty of Tissue Regenix's future price movements. The chart of the probability distribution of Tissue Regenix daily returns describes the distribution of returns around its average expected value. We use Tissue Regenix Group price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Tissue Regenix returns is essential to provide solid investment advice for Tissue Regenix.
| Mean Return | 0.13 | Value At Risk | -1.85 | Potential Upside | 3.45 | Standard Deviation | 1.53 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Tissue Regenix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Tissue Regenix Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 7.2M | (3.9M) | (746.1K) | (1.3M) | (1.2M) | (1.1M) | |
| Free Cash Flow | (6.8M) | (3.9M) | (2.3M) | 177K | 159.3K | 167.3K | |
| Depreciation | 762K | 793.3K | 921.4K | 786.0K | 903.9K | 502.5K | |
| Capital Expenditures | 1.4M | 1.5M | 884.9K | 863K | 992.5K | 569.6K | |
| Net Income | (9.7M) | (3.5M) | (2.2M) | (1.7M) | (1.5M) | (1.6M) | |
| End Period Cash Flow | 9.6M | 5.7M | 4.9M | 4.7M | 4.2M | 4.0M | |
| Other Non Cash Items | 10.9M | 2.5M | 2.7M | 1.8M | 2.1M | 2.3M | |
| Change To Inventory | (2.9M) | (83.6K) | (944.2K) | 411.0K | 369.9K | 388.4K | |
| Change To Netincome | 1.6M | 6.7M | 1.1M | 797K | 916.6K | 992.5K | |
| Investments | (1.4M) | (2.0M) | (1.1M) | (837K) | (962.6K) | (1.0M) |
Tissue Regenix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Tissue Regenix or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Tissue Regenix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Tissue stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | -0.28 | |
σ | Overall volatility | 1.56 | |
Ir | Information ratio | 0.07 |
Tissue Regenix Volatility Alert
Tissue Regenix Group currently demonstrates below-average downside deviation. It has Information Ratio of 0.07 and Jensen Alpha of 0.13. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Tissue Regenix's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Tissue Regenix's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Tissue Regenix Fundamentals Vs Peers
Comparing Tissue Regenix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Tissue Regenix's direct or indirect competition across all of the common fundamentals between Tissue Regenix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Tissue Regenix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Tissue Regenix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Tissue Regenix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Tissue Regenix to competition |
| Fundamentals | Tissue Regenix | Peer Average |
| Return On Equity | -0.0331 | -0.31 |
| Return On Asset | 0.005 | -0.14 |
| Profit Margin | (0.03) % | (1.27) % |
| Operating Margin | 0.03 % | (5.51) % |
| Current Valuation | 47.34 M | 16.62 B |
| Shares Outstanding | 71.23 M | 571.82 M |
| Shares Owned By Insiders | 51.91 % | 10.09 % |
| Shares Owned By Institutions | 34.85 % | 39.21 % |
| Price To Book | 1.72 X | 9.51 X |
| Price To Sales | 1.31 X | 11.42 X |
| Revenue | 29.49 M | 9.43 B |
| Gross Profit | 11.26 M | 27.38 B |
| EBITDA | 446 K | 3.9 B |
| Net Income | (1.67 M) | 570.98 M |
| Total Debt | 9.39 M | 5.32 B |
| Book Value Per Share | 0.43 X | 1.93 K |
| Cash Flow From Operations | 1.04 M | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Target Price | 120.0 | |
| Number Of Employees | 82 | 18.84 K |
| Beta | 1.58 | -0.15 |
| Market Capitalization | 41.67 M | 19.03 B |
| Total Asset | 43.24 M | 29.47 B |
| Retained Earnings | (123.76 M) | 9.33 B |
| Working Capital | 14.36 M | 1.48 B |
| Net Asset | 43.24 M |
Tissue Regenix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Tissue . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0256 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 57.75 | |||
| Day Typical Price | 58.0 | |||
| Market Facilitation Index | 1.5 | |||
| Period Momentum Indicator | (1.50) |
About Tissue Regenix Buy or Sell Advice
When is the right time to buy or sell Tissue Regenix Group? Buying financial instruments such as Tissue Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Tissue Regenix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Insurance Thematic Idea Now
Insurance
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Insurance theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Tissue Stock
Tissue Regenix financial ratios help investors to determine whether Tissue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tissue with respect to the benefits of owning Tissue Regenix security.